Related Experiment Video
Updated: Jan 27, 2026
06:38
Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
Published on: November 8, 2011
41.2K
Novel Therapeutics for Epstein⁻Barr Virus
Graciela Andrei1, Erika Trompet2, Robert Snoeck3
1Laboratory of Virology and Chemotherapy, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, 3000 Leuven, Belgium. graciela.andrei@kuleuven.be.
Molecules (Basel, Switzerland)
|March 16, 2019
Summary
Epstein-Barr virus (EBV) infects most adults, causing infectious mononucleosis and cancers like lymphomas in immunocompromised individuals. Current antivirals show limited success, necessitating new treatment strategies for EBV infections.
Area of Science:
- Virology
- Immunology
- Oncology
Background:
- Epstein-Barr virus (EBV), a human gamma-herpesvirus, infects up to 95% of adults, typically asymptomatically in childhood.
- Primary EBV infection can cause infectious mononucleosis and establishes latency in B-cells and epithelial cells.
- EBV is oncogenic, with reactivation under immunosuppression leading to B-cell lymphomas and nasopharyngeal carcinoma.
Purpose of the Study:
- To review clinically evaluated antiviral drugs for EBV infections.
- To discuss novel molecules and emerging strategies for treating EBV-related diseases.
Main Methods:
- Literature review of clinical trials and preclinical investigations of antiviral agents targeting EBV.
- Analysis of current therapeutic approaches and future directions for EBV management.
Main Results:
- Existing antiviral drugs have demonstrated limited clinical success in treating EBV infections.
- No antiviral drug is currently approved for EBV treatment.
- Several novel molecules and therapeutic strategies are under investigation for anti-EBV activity.
Conclusions:
- Effective antiviral therapies for EBV infections remain a significant clinical challenge.
- Ongoing research into novel molecules and treatment strategies holds promise for managing EBV-related diseases.
- Further clinical evaluation is crucial for developing approved treatments for EBV.
Related Concept Videos
00:50What are Viruses?
128.0K
Overview
128.0K
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
01:30Therapeutic Communication
7.8K
Communication is a lifelong learning process. Through therapeutic communication, nurses can collect relevant assessment data, provide education and counseling, and interact during nursing interventions. Sending and receiving messages occur through verbal and nonverbal communication techniques and can happen separately or simultaneously.
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
7.8K
01:29Microorganisms in Medicine and Therapeutics
1.1K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.1K
01:26Cholinergic Antagonists: Therapeutic Uses
1.4K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.4K
01:30Adrenergic Agonists: Therapeutic Uses
1.9K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.9K